NCT03723304View on ClinicalTrials.gov

The Intention-to-treat Effect of Bridge Therapies in the Setting of Milan-in Patients

CompletedOBSERVATIONAL
Enrollment

1,083

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

October 15, 2018

Study Completion Date

October 15, 2018

Conditions
Liver CancerTransplant; Failure, Liver
Interventions
PROCEDURE

Bridging followed by transplant

Trans-arterial chemoembolization or percutaneous alcohol injection or radio-frequency ablation during the waiting time followed by liver transplant

PROCEDURE

Direct liver transplant

Direct liver transplant (no neoadjuvant approaches during the waiting time period)

Trial Locations (1)

Unknown

UCL, Brussels

All Listed Sponsors
lead

European Hepatocellular Cancer Liver Transplant Group

OTHER

NCT03723304 - The Intention-to-treat Effect of Bridge Therapies in the Setting of Milan-in Patients | Biotech Hunter | Biotech Hunter